Table 2 Resource consumption
From: Budgetary impact analysis of buprenorphine-naloxone combination (Suboxone®) in Spain
| HTP | LITP | ||||||
|---|---|---|---|---|---|---|---|
| Resource | MAW | Methadone 1 st year | Methadone 2 nd & 3 rd year | B/N 1 st year | B/N 2 nd & 3 rd year | Methadone | B/N |
| Distribution | 365 | 365 | |||||
| Production | 365 | 365 | 365 | ||||
| Dispensing | 36 | 104 | 52 | 52 | |||
| Supervision | |||||||
| drug-pharmacy | 36 | 365 | 365 | 365 | |||
| medical/clinical | 6 | 6 | |||||
| psychological | 20 | 20 | 10 | 20 | 5 | ||
| social worker | 15 | 10 | 10 | 10 | 5 | 6 | 6 |
| psychiatric | 10 | 10 | 10 | 10 | 5 | ||
| Monitoring (analytical controls) | 36 | 12 | 12 | 12 |